Common hereditary cancer syndromes

Seminars in Oncology Nursing

Volumn 20, Issue 3, 2004, Pages 164-177

  Greco, Karen E ^a   Mahon, Suzanne ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN CANCER; BREAST CANCER; CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CANCER; DECISION MAKING; ETHNIC GROUP; FAMILIAL CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HEALTH CARE; HUMAN; INFORMATION DISSEMINATION; INFORMED CONSENT; LAW; LIFE EXPECTANCY; ONCOGENE; ONSET AGE; OVARY CANCER; PREDICTION; PROSTATE CANCER; RISK ASSESSMENT; RISK REDUCTION; X CHROMOSOME; Y CHROMOSOME;

GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY; NURSING ASSESSMENT; NURSING METHODOLOGY RESEARCH; ONCOLOGIC NURSING; RISK FACTORS;

EID: 4143105004     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.soncn.2004.04.003     Document Type: Article

References (61)

1. Fearon E.R. Human cancer syndromes clues to the origin and nature of cancer. Science. 278:1997;1043-1050
2. Greco K., Anderson G. Redressing policy in cancer genetics moving toward transdisciplinary teams. Policy Politics Nurs Pract. 3:2002;129-139
3. Frank T.S., Braverman A.M. The pros and cons of genetic testing for breast and ovarian cancer risk. Int J Fertil Womens Med. 44:1999;139-145
4. Lea D.H., Jenkins J.F., Francomano C.A. Genetics in clinical practice new directions for nursing and health care. 1998;Jones and Bartlett, Boston, MA
5. Mahon S.M. Cancer-risk assessment considerations for cancer genetics. 2003;Oncology Nursing Press, Pittsburgh, PA
6. Gould R., Lynch H., Smith R., et al. Cancer and genetics answering patients' questions. 1997;American Cancer Society, New York, NY
7. Frank T.S., Manley S.A., Olopade O.I., et al. Sequence analysis of BRCA1 and BRCA2 correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 16:1998;2417-2425
8. Lindor N.M., Greene M.H. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst. 90:1998;1039-1071
9. Spahis J. Human genetics constructing a family pedigree. Am J Nurs. 102:2002;44-50
10. Bennett R.L., Steinhaus K.A., Uhrich S.B., et al. Recommendations for standardized human pedigree nomenclature. Pedigree Standardization Task Force of the National Society of Genetic Counselors. [comment] Am J Hum Genet. 56:1995;745-752
11. Barse P.M. How to perform a genetic assessment. Tranin A.S., Masny A., Jenkins J. Genetics in oncology practice cancer risk assessment. 2003;57-76 Oncology Nursing Press, Pittsburgh, PA
12. Schneider K. Counseling about cancer strategies for genetic counseling. Ed 2 :2002;Wiley-Liss, New York, NY
13. Frank T.S. Laboratory determination of hereditary susceptibility to breast and ovarian cancer. Arch Pathol Lab Med. 123:1999;1023-1026
14. Collaborative Group on Hormonal Factors in Breast Cancer (CGoHFiB). Familial breast cancer collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. [comments] Lancet. 358:2001;1389-1399
15. Colditz G. Epidemiology of breast cancer findings from the Nurses Health Study. Cancer Suppl. 71:1993;1480-1489
16. American Cancer Society. Cancer Facts and Figures 2003. 2003;1-48 American Cancer Society, Atlanta, GA
17. Gail M.H., Brinton L.A., Byar D.P., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 81:1989;1879-1886
18. Bondy M.L., Lustbader E.D., Halabi S., et al. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst. 86:1994;620-625
19. Euhus D.M., Leitch A.M., Huth J.F., et al. Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast J. 8:2002;23-27
20. Claus E.B., Schildkraut J.M., Thompson W.D., et al. The genetic attributable risk of breast and ovarian cancer. Cancer. 77:1996;2318-2324
21. Claus E.B., Risch N., Thompson W.D. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer. 73:1994;643-651
22. Claus E.B., Risch N.J., Thompson W.D. Age at onset as an indicator of familial risk of breast cancer. [comment] Am J Epidemiol. 131:1990;961-972
23. Couch F.J., DeShano M.L., Blackwood M.A., et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 336:1997;1409-1415
24. Domchek S.M., Eisen A., Calzone K., et al. Application of breast cancer risk prediction models in clinical practice. J Clin Oncol. 21:2003;593-601
25. Shattuck-Eidens D., McClure M., Simard J., et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA. 273:1995;535-541
26. Berry D.A., Parmigiani G., Sanchez J., et al. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. [see comment] J Natl Cancer Inst. 89:1997;227-238
27. Berry D.A., Iversen E.S. Jr, Gudbjartsson D.F., et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. [see comment] J Clin Oncol. 20:2002;2701-2712
28. Euhus D.M. Understanding mathematical models for breast cancer risk assessment and counseling. Breast J. 7:2001;224-232
29. Vasenm H.F., Stormorken A., Menko F.H., et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol. 19:2001;4074-4080
30. Wijnen J.T., Vasen H.F., Khan P.M., et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med. 339:1998;511-518
31. Consortium T.B.C.L. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 91:2001;1310-1316
32. Ford D., Easton D.F., Stratton M., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 62:1998;676-689
33. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update genetic testing for cancer susceptibility. J Clin Oncol. 21:2003;2397-2406
34. FitzGerald M.G., MacDonald D.J., Krainer M., et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 334:1996;143-149
35. Struewing J.P., Hartge P., Wacholder S., et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. [see comments] N Engl J Med. 336:1997;1401-1408
36. Serova O.M., Mazoyer S., Puget N., et al. Mutations in BRCA1 and BRCA2 in breast cancer families are there more breast cancer-susceptibility genes? Am J Hum Genet. 60:1997;486-495
37. Liede A., Metcalfe K., Hanna D., et al. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet. 67:2000;1494-1504
38. Lynch H.T., Watson P., Narod S.A. The genetic epidemiology of male breast carcinoma. Cancer. 86:1999;744-746
39. Thompson D., Easton D. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet. 68:2001;410-419
40. Bell D.W., Erban J., Sgroi D.C., et al. Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. Cancer Res. 62:2002;2741-2743
41. Moslehi R., Russo D., Phelan C., et al. An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2. Clin Genet. 57:2000;70-73
42. Greco K. Genetic counseling and screening. Jennings-Dozier K., Mahon S.M. Cancer prevention, detection, and control a nursing perspective. 2002;727-766 Oncology Nursing Press, Pittsburgh, PA
43. Lerman C., Croyle R.T., Tercyak K.P., et al. Genetic testing psychological aspects and implications. J Consult Clin Psychol. 70:2002;784-797
44. Croyle R.T., Achilles J.S., Lerman C. Psychologic aspects of cancer genetic testing a research update for clinicians. Cancer. 80:1997;569-575
45. Geller G., Botkin J.R., Green M.J., et al. Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent. [see comments] JAMA. 277:1997;1467-1474
46. Press N., Yasui Y., Reynolds S., et al. Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. Am J Med Genet. 99:2001;99-110
47. Botkin J.R., Croyle R.T., Smith K.R., et al. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J Natl Cancer Inst. 88:1996;872-882
48. American Society of Human Genetics/American College of Medical Genetics. ASHG/ACMG report: points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 57:1995;1233-1241
49. American Gastrological Association. Colorectal cancer screening and surveillance clinical guidelines and rationale. Gastroenterology. 124:2003;544-560
50. Patenaude A.J. The genetic testing of children for cancer susceptibility ethical, legal, and social issues. Behav Sci Law. 14:1996;393-410
51. Dickens B., Pei N., Taylor K. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian, and colon cancer. Can Med Assoc J. 154:1996;813-818
52. Fanos J. Developmental tasks of childhood and adolescence implications for genetic testing. Am J Med Genet. 71:1997;22-28
53. Frank T.S. Hereditary risk of breast and ovarian carcinoma the role of the oncologist. Oncologist. 3:1998;403-412
54. Greco K. How to provide genetic counseling and education. Masney A., Strauss Tranin A., Jenkins J. Guidelines for cancer genetics nursing practice and education. 2003;189-219 Oncology Nursing Press, Pittsburgh, PA
55. Burke W., Petersen G., Lynch P., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA. 277:1997;915-919
56. Burke W., Daly M., Garber J., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 277:1997;997-1003
57. National Comprehensive Cancer Network. Breast cancer screening and diagnosis guidelines. National Comprehensive Cancer Network. Vol 2003:2002
58. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance clinical guidelines and rationale-update based on new evidence. Gastroenterology. 124:2003;544-560
59. Frank Stromborg M. They're real and they're here the new federally regulated privacy rules under HIPAA. Medsurg Nurs. 12:2003;380-385
60. Greco K. Nursing in the genomic era nurturing our genetic nature. Medsurg Nurs. 12:2003;307-317
61. Olsen S.J., Feetham S.L., Jenkins J., et al. Creating a nursing vision for leadership in genetics. Medsurg Nurs. 12:2003;177-183